Will Trigg

Will Trigg is a pharmaceutical and diagnostic program and project leader with over 25 years of experience in discovery, development, and manufacturing. They have led a variety of oncology and neurology projects, from early-phase hit discovery to clinical trials, including small molecules, antibodies, and cell therapies. Currently, as the Global Development Lead at Telix Pharmaceuticals Limited, Will focuses on early-stage oncology clinical development. Previously, they held senior positions at AstraZeneca, Ipsen, and ADAPTIMMUNE LIMITED, where they contributed to significant advancements in project management and innovative therapies. Will holds a PhD in Medicinal Chemistry from the University of Bath and a BSc in Pharmacology and Chemistry from The University of Sheffield.